Skip to content
FY'25FY'24FY'23FY'22
Profitability
Gross margin49.5%-1.6pp51.1%-3.4pp54.5%+4.6pp49.9%+4.2pp
Operating margin19.5%-8.6pp28.1%-2.5pp30.6%+9.0pp21.5%+5.6pp
Net margin13.6%-8.2pp21.8%+0.4pp21.3%+3.0pp18.3%+4.1pp
Efficiency
Asset turnover0.4×0.0×0.5×-0.1×0.6×-0.1×0.7×0.0×
Liquidity
Current ratio+0.9×3.1×+0.9×2.2×-1.8×+0.9×
Leverage
Net debt / EBITDA2.5×+0.5×1.9×-0.1×+2.4×-0.4×-0.2×
Valuation
Market capitalization$926.83M-19.9%$1.79B-39.7%$2.96B+119%$1.35B+21.5%
Price / earnings11.7×+3.5×11.2×-10.4×21.5×+6.7×14.8×-3.1×
Price / sales1.3×-0.3×2.4×-2.2×4.6×+1.9×2.7×+0.2×
EV / EBITDA8.3×+1.7×8.8×-5.8×14.6×+4.8×9.8×-1.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Amphastar Pharmaceuticals's profit margins?
Amphastar Pharmaceuticals (AMPH) runs a 47.3% gross margin and a 16.2% operating margin, with a 11.0% net margin.
Where do Amphastar Pharmaceuticals's ratios come from?
Every ratio is computed from Amphastar Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.